"10.1371_journal.pone.0085911","plos one","2014-01-17T00:00:00Z","Edward R Samuel; Lorea Beloki; Katy Newton; Stephen Mackinnon; Mark W Lowdell","Department of Haematology, University College London, Royal Free Campus, London, United Kingdom; Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain; Cell Medica Ltd, and University College London, London, United Kingdom; Department of Haematology, University College London and The Royal Free London NHS Foundation Trust, London, United Kingdom","Conceived and designed the experiments: ERS MWL KN. Performed the experiments: ERS LB. Analyzed the data: ERS LB MWL KN. Contributed reagents/materials/analysis tools: ERS KN. Wrote the paper: ERS MWL SM.","The authors have the following interests. MWL, SM and KN are shareholders in Cell Medica Ltd., a clinical-stage cellular therapeutics company, and KN is employed by Cell Medica Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","01","Edward R Samuel","ERS",5,TRUE,3,2,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
